Geode Capital Management LLC Has $537.05 Million Holdings in Waters Co. (NYSE:WAT)

Geode Capital Management LLC boosted its holdings in Waters Co. (NYSE:WAT - Free Report) by 2.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,451,445 shares of the medical instruments supplier's stock after acquiring an additional 34,762 shares during the quarter. Geode Capital Management LLC owned about 2.44% of Waters worth $537,053,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Vanguard Group Inc. boosted its stake in shares of Waters by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 7,098,668 shares of the medical instruments supplier's stock worth $2,633,464,000 after acquiring an additional 19,456 shares in the last quarter. Wealthfront Advisers LLC increased its stake in shares of Waters by 106,144.4% in the fourth quarter. Wealthfront Advisers LLC now owns 3,087,461 shares of the medical instruments supplier's stock worth $1,145,386,000 after acquiring an additional 3,084,555 shares during the last quarter. Alliancebernstein L.P. raised its stake in shares of Waters by 8.7% during the 4th quarter. Alliancebernstein L.P. now owns 2,654,002 shares of the medical instruments supplier's stock worth $984,582,000 after purchasing an additional 212,364 shares in the last quarter. State Street Corp raised its position in Waters by 1.9% during the third quarter. State Street Corp now owns 2,577,733 shares of the medical instruments supplier's stock valued at $927,700,000 after acquiring an additional 49,194 shares in the last quarter. Finally, AKO Capital LLP lifted its stake in shares of Waters by 3.2% in the 4th quarter. AKO Capital LLP now owns 815,379 shares of the medical instruments supplier's stock valued at $302,489,000 after purchasing an additional 25,172 shares during the last quarter. 94.01% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Analyst Upgrades and Downgrades

Several research firms recently weighed in on WAT. Wells Fargo & Company boosted their target price on Waters from $415.00 to $420.00 and gave the stock an "overweight" rating in a report on Thursday, February 13th. Robert W. Baird upgraded Waters from a "neutral" rating to an "outperform" rating and boosted their price target for the company from $396.00 to $407.00 in a research note on Wednesday, March 26th. JPMorgan Chase & Co. increased their price objective on shares of Waters from $380.00 to $390.00 and gave the company a "neutral" rating in a research note on Thursday, March 6th. UBS Group boosted their price target on Waters from $405.00 to $410.00 and gave the company a "neutral" rating in a research note on Thursday, February 13th. Finally, Baird R W raised shares of Waters from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, March 26th. Ten analysts have rated the stock with a hold rating, seven have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $401.31.

Waters Trading Up 9.2 %

NYSE:WAT traded up $28.21 during trading hours on Wednesday, hitting $335.92. The stock had a trading volume of 1,254,586 shares, compared to its average volume of 472,796. The business's 50 day moving average is $372.44 and its 200-day moving average is $372.68. The company has a market cap of $19.96 billion, a price-to-earnings ratio of 31.37, a P/E/G ratio of 3.79 and a beta of 1.04. Waters Co. has a one year low of $279.24 and a one year high of $423.56. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.65 and a current ratio of 0.94.

Waters (NYSE:WAT - Get Free Report) last posted its earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share for the quarter, topping the consensus estimate of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. Sell-side analysts anticipate that Waters Co. will post 12.86 EPS for the current fiscal year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.